Bridge the gap between research and the clinic with our translational biomarker services, designed to turn discoveries into actionable clinical insights. Our offerings include biomarker validation, confirming the clinical relevance of your biomarkers across both preclinical and patient samples. We provide custom assay development, offering tailored solutions for biomarker detection in tissues, biofluids and other sample types. Our multimodal analysis integrates genomics, proteomics and imaging data to provide a holistic view of biomarker performance. Additionally, we generate robust, high-quality and submission-ready data to support regulatory requirements.
Our indication profiling services utilise immunohistochemistry (IHC) and comprehensive clinical sample collections, including tumour microarrays (TMAs). This approach allows for histopathological assessment and scoring of expression (H-Score) by a pathologist or through semi-automated quantification. Adhering to good clinical practice (GCP), our clinical sample biomarker analysis follows FDA and EMA guidelines, helping ensure compliance with bioanalytical method validation standards. Our expertise in exploratory biomarker analysis enables us to provide reliable and validated results.
Contact Us
Search